Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Software Group Regulatory News (APTD)

Share Price Information for Aptitude Software Group (APTD)

Share Price is delayed by 15 minutes
Get Live Data
212.00    -6.00 (-2.75%)
Bid:
209.00
Ask:
216.00
Spread: 7.00 (3.349%)
Market Cap: £111.93m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Software Group Share Chart

Board Transition

5 Feb 2025 07:01

RNS Number : 9187V
Aptitude Software Group PLC
05 February 2025
 

5 February 2025

Aptitude Software Group plc

("Aptitude", "the Group")

Board Transition

Aptitude (LSE:APTD), a market-leading provider of finance transformation software solutions, specialising in fully autonomous finance, today provides an update regarding a Board change.

The Aptitude organisation has been realigned to support the new product and business priorities, including the creation of a smaller, globally integrated senior management team with increased travel requirements and expanded spans of control. As a result, by mutual agreement, Mike Johns will step down from his role as CFO and from the Aptitude Board. Mike has agreed to remain in his role and as a Director of the Group to support the business, oversee the Full Year 2024 results and ensure an orderly transition. The search for his successor has commenced, and the Group will share further details in due course.

The Board would like to extend its thanks to Mike for his support of Aptitude over his seven years with the Group. In preparation for this transition, the financial and commercial functions have been strengthened while we appoint Mike's successor. A further update will be provided when Mike steps down from the Aptitude Board.

 

Aptitude Software Group plc

020-3687-3200

 

Alex Curran, Chief Executive Officer

Ivan Martin, Chairman

 

Mike Johns, Chief Financial Officer

 

 

 

Canaccord Genuity Limited

020-7523-8000

Simon Bridges / Andrew Potts

 

 

 

Alma Strategic Communications

 

Caroline Forde / Hilary Buchanan

020-3405-0205

 

 About Aptitude Software

Aptitude Software provides software solutions that deliver fully autonomous finance to enable its clients to drive growth, efficiency and sustainability. Fynapse is Aptitude's intelligent finance data management and accounting platform designed to increase productivity and lower costs for finance teams globally. Fynapse provides a single view of finance and business data, unparalleled performance and automation, faster and better insights, user-friendly functionality and market-leading total cost of ownership

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASSUFALEISEIE
Date   Source Headline
29th Apr 20257:00 amRNSNotice of 2025 Annual General Meeting
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20254:16 pmRNSExercise of awards under the Aptitude 2020 DBP
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSAptitude Fynapse New Contract Win
3rd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 202511:49 amRNSTotal Voting Rights
31st Mar 202510:29 amRNSNotification of Major Holdings
31st Mar 202510:11 amRNSBLOCK LISTING SIX MONTHLY RETURN
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20255:01 pmRNSNotification of Major Holdings
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20255:10 pmRNSDirectorate Change
26th Mar 20257:00 amRNSAudited Results for Year Ended 31 December 2024
20th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20258:46 amRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20257:00 amRNSTransaction in Own Shares
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSTransaction in Own Shares
13th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20257:01 amRNSBoard Transition
5th Feb 20257:00 amRNSFull Year Trading Update and Notice of Results
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 202510:43 amRNSTotal Voting Rights
31st Jan 20255:39 pmRNSNotification of Major Holdings
30th Jan 20254:58 pmRNSNotification of Major Holdings
30th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
23rd Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
21st Jan 20257:00 amRNSTransaction in Own Shares
17th Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 202510:41 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.